<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120127008830N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-23</date_registration>
      <primary_sponsor>Vice chancellor for Research and Technology, Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The efficacy of Simvastatin in maxillary sinus augmentation</public_title>
      <acronym></acronym>
      <scientific_title>Radiographic analysis of the efficacy of Simvastatin in combination with bone graft with bovis origin in maxillary sinus augmentation: A randomized controlled clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>12</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/29017</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Flipping a coin is used for randomization, Blinding description: Surgeons are not  blind to the materials used in the site of surgery. However, examiner who performs the radiographic evaluations is blind to the treatment and doesn't conduct or supervise the surgery.</study_design>
      <phase>4</phase>
      <hc_freetext>bone loss in the posterior maxillary edentulous ridge.</hc_freetext>
      <i_freetext>Intervention 1: Control side: Each subject takes 2 gr amoxicillin or 600 mg clindamycin as  antibiotic prophylaxis one hour before surgery. Clinical photographs are taken before, during and post-surgery. Procedures carry out under local anesthesia with different anesthetic. By reflection a full thickness flap, the lateral wall of the sinus is exposed. Osteotomy of the lateral sinus wall is performed with rotary burs. The wall and sinus membrane are elevated. Bovine bone substitute alone is placed. A resorbable collagen membrane is hydrated in sterile saline before to insertion and is placed over the lateral window. Primary flap closure will be obtained with silk or vicryl yarn. A postoperative CBCT is taken to ensure that all graft materials are in place. Appropriate antibiotics and analgesics will be prescribed for 7-10 days and chlorhexidine gluconate 0.2% will be prescribed for two weeks. The patients will be asked to return to the clinic 7-10 days after surgery for suture removal and postoperative assessment. Intervention 2: Intervention side: Each subject takes 2 gr amoxicillin or 600 mg clindamycin as antibiotic prophylaxis one hour before surgery. Clinical photographs are taken before, during and post-surgery. Procedures carry out under local anesthesia with different anesthetic. By reflection a full thickness flap, the lateral wall of the sinus is exposed. Osteotomy of the lateral sinus wall is performed with rotary burs. The wall and sinus membrane are elevated. Simvastatin solution (8 mg SMV in 0.5 cc ethanol 70%), 0.5 cc, is mixed with 1 cc bovine bone substitute and is placed in the intervention site. The same ratios of SMV to bovine bone substitute are used if any additional materials require filling sinuses. A resorbable collagen membrane is hydrated in sterile saline before to insertion and is placed over the lateral window. Primary flap closure will be obtained with silk or vicryl yarn. A postoperative CBCT is taken to ensure that all graft materials are in place. Appropriate antibiotics and analgesics will be prescribed for 7-10 days and chlorhexidine gluconate 0.2% will be prescribed for two weeks. The patients will be asked to return to the clinic 7-10 days after surgery for suture removal and postoperative assessment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shakiba Farahani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dentistry School, Tehran University of Medical Science, North Karegar Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55991</zip>
        <telephone>+98 21 8801 5950</telephone>
        <email>farahanishakiba@yahoo.com</email>
        <affiliation>Dentistry School, Tehran University of medical Science</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Siamak Yaghobee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dentistry School, Tehran University of Medical Science, North Karegar Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14399-55991</zip>
        <telephone>+98 21 8801 5950</telephone>
        <email>Yaghobee@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with age over 18
Desiring to receive maxillary posterior implants
Not having sufficient bone determined on CBCT for dental implant
The patients are partially or completely toothless in the posterior maxilla
Patients who need bilateral maxillary sinus augmentation surgeries</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Needing antibiotic prophylaxis for dental procedures
Any sinus pathology (acute or chronic) contraindicating the sinus graft surgery 
Patients with systemic disease contraindicating any oral surgeries
Patients who smoke more than 10 cigarettes daily
Women who are pregnant or wish to become pregnant during the period of the study
Diseases or medications known to affect bone metabolism ,tissue regeneration and repair such as corticosteroids, bisphosphonates and etc
Patients with a history of alcoholism or drug abuse
Patients who have a history of cancer or radiation to the head and neck</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control side: Each subject takes 2 gr amoxicillin or 600 mg clindamycin as  antibiotic prophylaxis one hour before surgery. Clinical photographs are taken before, during and post-surgery. Procedures carry out under local anesthesia with different anesthetic. By reflection a full thickness flap, the lateral wall of the sinus is exposed. Osteotomy of the lateral sinus wall is performed with rotary burs. The wall and sinus membrane are elevated. Bovine bone substitute alone is placed. A resorbable collagen membrane is hydrated in sterile saline before to insertion and is placed over the lateral window. Primary flap closure will be obtained with silk or vicryl yarn. A postoperative CBCT is taken to ensure that all graft materials are in place. Appropriate antibiotics and analgesics will be prescribed for 7-10 days and chlorhexidine gluconate 0.2% will be prescribed for two weeks. The patients will be asked to return to the clinic 7-10 days after surgery for suture removal and postoperative assessment.</i_keyword>
      <i_keyword>Intervention side: Each subject takes 2 gr amoxicillin or 600 mg clindamycin as antibiotic prophylaxis one hour before surgery. Clinical photographs are taken before, during and post-surgery. Procedures carry out under local anesthesia with different anesthetic. By reflection a full thickness flap, the lateral wall of the sinus is exposed. Osteotomy of the lateral sinus wall is performed with rotary burs. The wall and sinus membrane are elevated. Simvastatin solution (8 mg SMV in 0.5 cc ethanol 70%), 0.5 cc, is mixed with 1 cc bovine bone substitute and is placed in the intervention site. The same ratios of SMV to bovine bone substitute are used if any additional materials require filling sinuses. A resorbable collagen membrane is hydrated in sterile saline before to insertion and is placed over the lateral window. Primary flap closure will be obtained with silk or vicryl yarn. A postoperative CBCT is taken to ensure that all graft materials are in place. Appropriate antibiotics and analgesics will be prescribed for 7-10 days and chlorhexidine gluconate 0.2% will be prescribed for two weeks. The patients will be asked to return to the clinic 7-10 days after surgery for suture removal and postoperative assessment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Alveolar bone height on Cone Beam Computed Tomograghy. Timepoint: Preoperative, immediately and 9 months after sinus graft. Method of measurement: Cone Beam Computed Tomography:Two lines which are the mesial and distal limits of the augmented area and a center point between these two lines were selected on Cone Beam Computed Tomographys that were taken. Alveolar bone height in these three lines measured and the average of these measurements was reported as mean alveolar bone height.</prim_outcome>
      <prim_outcome>Alveolar bone density on Cone Beam Computed Tomograghy. Timepoint: preoperatively, immediately and at 9 months after sinus graft. Method of measurement: Cone Beam Computed Tomography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for Research and Technology, Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-01-13</approval_date>
        <contact_name>Ethics committe of Tehran University of Medical Sciences</contact_name>
        <contact_address>Dentistry School, Tehran University of Medical Science, North Karegar Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
